article thumbnail

Blood thinners added to clot-busting medication did not improve stroke outcomes

American Heart News - Stroke News

Research Highlights: Although giving blood thinners along with clot-busting medication may help in treating heart attacks, it did not improve 90-day outcomes in people with clot-caused strokes. Enrollment in a large clinical trial, which had been.

article thumbnail

Arterial Connections Improve Treatment Outcomes Following Stroke

DAIC

Kulcsar, University Hospital Zurich milla1cf Mon, 02/26/2024 - 12:13 February 26, 2024 — Ischemic strokes are a major health burden. Many stroke patients recover poorly despite timely treatment To treat these symptoms and restore blood flow to the brain, the obstructed vessel needs to be “declogged”, or recanalized.

article thumbnail

Study finds good clinical outcomes for over 30% of ischemic stroke patients receiving endovascular treatment

Medical Xpress - Cardiology

Endovascular treatment for acute ischemic stroke patients beyond six hours from onset is still effective, according to a collaborative study conducted by the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and Queen Mary Hospital (QMH).

Stroke 94
article thumbnail

Top hospitals for stroke care: Healthgrades

Becker's Hospital Review - Cardiology

Of those, 99 hospitals were recognized for delivering superior clinical outcomes in the care and treatment of stroke. Healthgrades published its 2025 Specialty Excellence Awards recipients Oct.

article thumbnail

Allogeneic Stem Cell Therapy Falls Short on Stroke Outcomes

Med Page Today

(MedPage Today) -- Bone marrow-derived allogeneic stem cell therapy shortly after ischemic stroke did not improve outcomes at 90 days, a phase II/III randomized clinical trial known as TREASURE found. The rate of excellent outcomes -- a composite.

article thumbnail

Findings from MOST Trial Presented at ISC24: Blood thinners added to clot-busting medication did not improve stroke outcomes

DAIC

Findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial were presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, being held through Feb. The study was looking for improvement in functional outcomes at 90 days. 9 Phoenix, AZ.

Stroke 105
article thumbnail

World Stroke Organization, Philips Release Paper on Expanding Access to Stroke Care

DAIC

10, 2024 — Royal Philips and the World Stroke Organization (WSO) have published a policy paper calling for a revolution in stroke care to make a real difference to the lives of millions and bring significant economic benefits worldwide. tim.hodson Tue, 09/10/2024 - 13:18 Sept.

Stroke 96